Belgium Digestive System Disorder Medicine Sales is set to reach $925.2 Million by 2026 from $879.2 Million, is expected to be up 3.2% per year. Since 2017, the market was up 3.9% year on year attaining $36,680 Million. Japan, South Korea and Canada respectively were numbers 2, 3 and 4 in this ranking.
How does Belgium perform in Digestive System Disorder?
Forecast: Alimentary Tract and Metabolism Medicine Sales in Belgium
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use in Belgium
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Belgium
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Belgium
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Belgium
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Belgium
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Belgium
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Belgium
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Belgium
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Belgium
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research